GR852158B - - Google Patents

Info

Publication number
GR852158B
GR852158B GR852158A GR850102158A GR852158B GR 852158 B GR852158 B GR 852158B GR 852158 A GR852158 A GR 852158A GR 850102158 A GR850102158 A GR 850102158A GR 852158 B GR852158 B GR 852158B
Authority
GR
Greece
Prior art keywords
drug
tablet
active substance
core
particles
Prior art date
Application number
GR852158A
Other languages
English (en)
Inventor
Bo Magnus Ekman
Ake Rikard Lindahl
Original Assignee
Leo Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Ab filed Critical Leo Ab
Publication of GR852158B publication Critical patent/GR852158B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Control Of Temperature (AREA)
  • Slot Machines And Peripheral Devices (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
GR852158A 1984-09-06 1985-09-06 GR852158B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8404467A SE8404467D0 (sv) 1984-09-06 1984-09-06 Controlled-release medical preparations

Publications (1)

Publication Number Publication Date
GR852158B true GR852158B (el) 1986-01-08

Family

ID=20356934

Family Applications (1)

Application Number Title Priority Date Filing Date
GR852158A GR852158B (el) 1984-09-06 1985-09-06

Country Status (21)

Country Link
US (1) US4824678A (el)
EP (1) EP0173928B1 (el)
JP (1) JP2527713B2 (el)
KR (1) KR930003114B1 (el)
AT (1) ATE53490T1 (el)
AU (1) AU576891B2 (el)
CA (1) CA1252723A (el)
DE (1) DE3578123D1 (el)
DK (1) DK164256C (el)
ES (1) ES8702138A1 (el)
FI (1) FI87042C (el)
GR (1) GR852158B (el)
HU (1) HU194495B (el)
IE (1) IE58263B1 (el)
IL (2) IL76256A (el)
NO (1) NO169996C (el)
NZ (1) NZ213245A (el)
PH (1) PH22119A (el)
PT (1) PT81092B (el)
SE (1) SE8404467D0 (el)
ZA (1) ZA856547B (el)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4917899A (en) * 1983-12-22 1990-04-17 Elan Corporation Plc Controlled absorption diltiazem formulation
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
EP0153105B1 (en) * 1984-02-10 1992-09-09 Benzon Pharma A/S Diffusion coated multiple-units dosage form
US5624683A (en) * 1986-08-06 1997-04-29 Eisai Co., Ltd. Sustained-release multi-granule tablet
DE3720757A1 (de) * 1987-06-24 1989-01-05 Bayer Ag Dhp-manteltablette
US5073381A (en) * 1988-08-15 1991-12-17 University Of Akron Amphiphilic networks
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
US5178868A (en) * 1988-10-26 1993-01-12 Kabi Pharmacia Aktiebolaq Dosage form
SE8803822D0 (sv) * 1988-10-26 1988-10-26 Novel dosage form
US5149425A (en) * 1988-11-09 1992-09-22 Chembiomed, Ltd. Affinity supports for hemoperfusion
US5240601A (en) * 1988-11-09 1993-08-31 Chembiomed, Ltd. Affinity supports for hemoperfusion
EP0542926B1 (en) * 1990-08-07 1995-02-15 Pfizer Inc. Use of interfacially-polymerized membranes in delivery devices
US5288505A (en) * 1991-06-26 1994-02-22 Galephar P.R., Inc., Ltd. Extended release form of diltiazem
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
ZA933725B (en) * 1992-05-28 1993-12-15 Elan Corp Plc Tablet formulation
ES2113094T3 (es) * 1993-03-09 1998-04-16 Epic Therapeutics Inc Las microparticulas macromoleculares y metodos de obtencion.
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US5547948A (en) * 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
EP1005863A1 (en) * 1998-12-04 2000-06-07 Synthelabo Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
EP1064937A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
GB9923045D0 (en) * 1999-09-29 1999-12-01 Novartis Ag New oral formulations
US20060153914A1 (en) * 1999-12-10 2006-07-13 Biovail Laboratories International S.R.L. Chronotherapeutic diltiazem formulations and the administration thereof
US7108866B1 (en) 1999-12-10 2006-09-19 Biovall Laboratories International Srl Chronotherapeutic diltiazem formulations and the administration thereof
SK287684B6 (sk) 1999-12-20 2011-06-06 Schering Corporation Pevná orálna farmaceutická dávková forma s predĺženým uvoľňovaním
WO2001045676A2 (en) 1999-12-20 2001-06-28 Schering Corporation Extended release oral dosage composition
SE0100200D0 (sv) 2001-01-24 2001-01-24 Astrazeneca Ab New film coating
US6960357B2 (en) 2001-05-25 2005-11-01 Mistral Pharma Inc. Chemical delivery device
KR20040018394A (ko) * 2001-07-04 2004-03-03 썬 파마슈티컬 인더스트리스 리미티드 위 정체 제어되는 약물 전달 계
US6602911B2 (en) * 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
CA2435729C (en) * 2001-12-19 2005-12-13 Astrazeneca Ab New film coating
WO2003077897A1 (en) * 2002-03-15 2003-09-25 Cypress Bioscience, Inc. Ne and 5-ht reuptake inhibitors for treating visceral pain syndromes
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20040132826A1 (en) * 2002-10-25 2004-07-08 Collegium Pharmaceutical, Inc. Modified release compositions of milnacipran
GB0227948D0 (en) * 2002-11-29 2003-01-08 Cipla Ltd Pharmaceutical combinations comprising b-2 adrenoreceptor agonists and xanthines
CA2513893A1 (en) * 2003-01-28 2004-08-12 Collegium Pharmaceutical, Inc. Multiparticulate compositions of milnacipran for oral administration
US7862835B2 (en) * 2004-10-27 2011-01-04 Boston Scientific Scimed, Inc. Method of manufacturing a medical device having a porous coating thereon
US7994220B2 (en) * 2005-09-28 2011-08-09 Cypress Bioscience, Inc. Milnacipran for the long-term treatment of fibromyalgia syndrome
AU2006322314A1 (en) * 2005-11-18 2007-06-14 Synthon B.V. Zolpidem tablets
US7427414B2 (en) * 2006-01-18 2008-09-23 Astron Research Limited Modified release oral dosage form using co-polymer of polyvinyl acetate
CN102440992A (zh) * 2011-12-19 2012-05-09 岳阳新华达制药有限公司 含有盐酸班布特罗和多索茶碱复方制剂及其制备方法
EP3331502B1 (en) 2015-08-07 2021-05-26 Santa Farma Ilaç Sanayi A.S. Controlled release propiverine formulations
EP3796908B1 (en) 2018-11-16 2023-05-10 Santa Farma Ilaç Sanayi A.S. Controlled release propiverine formulations
WO2022115056A1 (en) 2020-11-27 2022-06-02 Santa Farma Ilac Sanayii A.S. Sustained release formulation compositions comprising propiverine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL108838C (el) * 1956-03-27
US3538214A (en) * 1969-04-22 1970-11-03 Merck & Co Inc Controlled release medicinal tablets
EP0013131A3 (en) * 1978-12-27 1981-01-07 Mundipharma A.G. Pharmaceutical composition in solid dosage form, and process for its production
US4557925A (en) * 1982-07-08 1985-12-10 Ab Ferrosan Membrane-coated sustained-release tablets and method
JPH075457B2 (ja) * 1983-08-16 1995-01-25 ザ ウエルカム フアウンデ−シヨン リミテツド 調節された方法による有効成分の放出を可能にする医薬組成物
US4769027A (en) * 1984-08-15 1988-09-06 Burroughs Wellcome Co. Delivery system

Also Published As

Publication number Publication date
JPS61112013A (ja) 1986-05-30
FI853406A0 (fi) 1985-09-05
HU194495B (en) 1988-02-29
FI853406L (fi) 1986-03-07
FI87042C (fi) 1992-11-25
NO853407L (no) 1986-03-07
NZ213245A (en) 1988-06-30
DK400685D0 (da) 1985-09-02
DK400685A (da) 1986-03-07
KR930003114B1 (ko) 1993-04-19
HUT40333A (en) 1986-12-28
US4824678A (en) 1989-04-25
NO169996B (no) 1992-05-25
ZA856547B (en) 1986-04-30
JP2527713B2 (ja) 1996-08-28
ES546728A0 (es) 1986-12-16
IL76256A (en) 1990-06-10
IL76257A (en) 1989-05-15
DE3578123D1 (de) 1990-07-19
CA1252723A (en) 1989-04-18
AU576891B2 (en) 1988-09-08
DK164256B (da) 1992-06-01
IL76256A0 (en) 1986-01-31
ES8702138A1 (es) 1986-12-16
SE8404467D0 (sv) 1984-09-06
EP0173928B1 (en) 1990-06-13
FI87042B (fi) 1992-08-14
PT81092A (en) 1985-10-01
DK164256C (da) 1992-10-19
KR860002271A (ko) 1986-04-24
IE58263B1 (en) 1993-08-25
EP0173928A1 (en) 1986-03-12
AU4693585A (en) 1986-03-13
PT81092B (pt) 1988-01-22
IE852070L (en) 1986-03-06
NO169996C (no) 1992-09-02
ATE53490T1 (de) 1990-06-15
PH22119A (en) 1988-06-01

Similar Documents

Publication Publication Date Title
GR852158B (el)
HUT59321A (en) Process for producing pharmaceutical compositions having controlled release of active ingredient
ATE150963T1 (de) Kugelförmige granula mit kern sowie deren herstellung
IE883810L (en) Sustained release pharmaceutical compositions
CA2281420A1 (en) Preparation of pharmaceutically-active granules
HUT56267A (en) Process for producing pharmaceutical compositions having controlled release of active ingredient
ES2001897A6 (es) Procedimiento para la fabricacion de una tableta de liberacion controlada
FI864108A (fi) Nytt farmaceutiskt preparat och foerfarande foer framstaellning av detsamma.
DE3767600D1 (de) Ibuprofen-formulation mit verzoegerter wirkstoffabgabe.
DE59806578D1 (de) Verwendung von redispergierbaren Polymerpulvern oder Polymergranulaten zum Überziehen von pharmazeutischen oder agrochemischen Darreichungsformen
CA2000932A1 (en) Oral pharmaceutical controlled release multiple unit dosage form
EP0616802A4 (en) PREPARATION ORALLY ADMINISTERED TO BE RELEASED IN THE LOWER DIGESTIVE TUBE.
NO170424C (no) Harpikspartikler av desintegrasjonstypen, deres fremstilling og beleggsmiddel inneholdende slike partikler
JPS54119585A (en) Production of polymer composition containing physiologically active substance
JPS5549312A (en) Preparation of slow-releasing medicine
AUPM814994A0 (en) Codeine-containing formulations